DALLAS, Oct. 13, 2026 /PRNewswire/ -- Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in two upcoming investor conferences:

• Goldman Sachs Healthcare Private Company Conference — Andy Doraiswamy (CEO) will present on Monday, October 19, 2026, at the Goldman Sachs Client Center in New York City.
• The MedTech Conference, hosted by AdvaMed^® — Damian Rippole (CFO) will present as part of the Bank of America Company Presentations on Tuesday, October 20, 2026, in Room 050 at the Thomas M. Menino Convention & Exhibition Center in Boston.

Doraiswamy and Rippole will highlight the company's commercial momentum for its vascular portfolio—including Dayspring^® non-pneumatic compression treatment for chronic edema—and share progress on its vascular pipeline and ongoing clinical research.

About Koya Medical

Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.

Learn more at www.koyamedical.com and follow Koya on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/koya-medical-to-present-at-october-2026-investor-conferences-302902990.html

SOURCE Koya Medical

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.